FDA, USA
International Regulatory Analyst
Ana Patricia (Patty) Pineda is an International Regulatory Analyst for Medical Products in the U.S. Food and Drug Administration’s (FDA) Latin America Office in Mexico City, since March, 2013 where she has developed the medical products portfolio in the Latin America region. Ms. Pineda holds a Bachelor on Sciences on Chemistry, Pharmacology and Biology from the National Autonomous University of Mexico and a Master on Sciences degree in Toxicology from the Center for Research and Advanced Studies of the National Polytechnic Institute of Mexico.
She started her professional career in the pharmaceutical industry in the manufacturing and production area. In 2001 she joined the Mexican Government as Head of the Toxicology Department of the Environmental Health General Directorate under the Ministry of Health of Mexico, participating in the development of the risk assessment area.
For ten years Ms. Pineda was Manager of International Affairs on Drugs at the Federal Commission for the Protection from Sanitary Risks (COFEPRIS), where she coordinated COFEPRIS’ participation and represented this Regulatory Authority in international fora regarding drugs, medical devices, dietary supplements, cosmetics, toxic substances and pesticides, such as Asia Pacific Economic Cooperation (APEC); the WHO World Health Assembly, the Pan American Network for Drug Regulation Harmonization (PANDRH); the International Pharmaceutical Regulators Forum (IPRF); the Global Health Task Force (GHTF), the US, Mexico and Canada Trilateral Cooperation; the United Nations Environment Programme; among others. Ms. Pineda also represented APEC as a Regional Harmonization Initiative at the International Conference of Harmonisation (ICH). She participated in the development and signature of several cooperation instruments on various areas.